Notice on Convening the First Extraordinary General Meeting of Shareholders in 2025
Securities code: 603087 Securities abbreviation: Ganli Pharmaceutical Announcement number: 2025-073 Ganli Pharmaceutical Co., Ltd.
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
Date of shareholders’ meeting: November 17, 2025
The online voting system adopted for this shareholders’ meeting: Shanghai Stock Exchange Shareholders’ Meeting Online Voting
system
1. Basic information on convening the meeting
(1) Type and session of shareholders’ meeting
The first extraordinary general meeting of shareholders in 2025
(2) Convener of the general meeting of shareholders: Board of Directors
(3) Voting method: The voting method adopted at this shareholders’ meeting is a combination of on-site voting and online voting.
way
(4) Date, time and place of on-site meeting
Date and time of the meeting: November 17, 2025 14:00
Venue: Conference Room 8, No. 8, Nanfengxi 1st Road, Miao County Town, Tongzhou District, Beijing
(5) Online voting system, start and end dates and voting time.
Online Voting System: Shanghai Stock Exchange Shareholders Meeting Online Voting System
Online voting starts and ends on November 17, 2025
Until November 17, 2025
Adopting the Shanghai Stock Exchange online voting system, the voting time of the voting platform through the trading system is
The trading time period on the day when the General Meeting of Shareholders is held is 9:15-9:25, 9:30-11:30, and 13:00-15:00; the voting time through the Internet voting platform is 9:15-15:00 on the day when the General Meeting of Shareholders is held.
(6) Voting procedures for margin financing and securities lending, refinancing, agreed repurchase business accounts and Shanghai-Hong Kong Stock Connect investors
Involving accounts related to margin trading and securities lending, refinancing business, agreed repurchase business, and Shanghai-Hong Kong Stock Connect investors
Voting shall be carried out in accordance with the "Shanghai Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 1 - Standardized Operations"
"Work" and other relevant regulations shall be implemented.
(7) Involving public solicitation of shareholder voting rights
Not involved
2. Matters to be considered at the meeting
Proposals to be considered at this general meeting of shareholders and types of voting shareholders
Voting shareholder type serial number Proposal name
Non-cumulative voting resolution for A-share shareholders
1 "About canceling the board of supervisors, amending the Articles of Association and handling industrial and commercial affairs √
Proposal to Change Registration》
2.00 "Proposal on Formulating and Amending Part of the Company's Governance System" √ 2.01 "About Amending the Meeting of Shareholders of Ganli Pharmaceutical Co., Ltd. √
Rules > Proposal
2.02 "About Amendments to the Board of Directors Meeting of Ganli Pharmaceutical Co., Ltd." √
Rules > Proposal
2.03 "About the revision of the external guarantee system of Ganli Pharmaceutical Co., Ltd. √
Degree>Proposal》
2.04 "About the Revision of Ganli Pharmaceutical Co., Ltd.'s External Investment Management" √
Management Measures>Proposal》
2.05 "About the Revision of Related Transaction Management of Ganli Pharmaceutical Co., Ltd." √
Management Measures>Proposal》
2.06 "About the revision of the independent director system of Ganli Pharmaceutical Co., Ltd. √
Degree>Proposal》
2.07 "About the Formulation<Director and Senior Director of Ganli Pharmaceutical Co., Ltd. √
Proposal on Management Measures for Remuneration of Managers>
2.08 "About the formulation of <Ganli Pharmaceutical Co., Ltd. Raised Funds Management √
Management Measures>Proposal》
2.09 "About the Formulation of Accounting Affairs of Ganli Pharmaceutical Co., Ltd. √
Proposal for Selected Recruitment System>
- The time and disclosure media of each proposal
The above proposal has been passed by the fourth meeting of the company's fifth session of the board of directors. For details, please refer to the company's relevant announcements published on the website of the Shanghai Stock Exchange (www.sse.com.cn) and the company's designated information disclosure media "Shanghai Securities News" and "China Securities News" on October 31, 2025.
Special resolutions: 1
Proposal to count votes separately for small and medium investors: 1
Proposals involving related shareholders’ avoidance of voting: None
Name of related shareholders who should avoid voting: None
- Proposals involving preference shareholders’ participation in voting: None
3. Things to note when voting at the general meeting of shareholders
(1) The shareholders of the Company who exercise their voting rights through the online voting system of the Shanghai Stock Exchange’s general meeting of shareholders can either log in to the trading system voting platform (through the trading terminal of the securities company designated for trading) to vote, or log in to the Internet voting platform (website: vote.sseinfo.com) to vote. When logging into the Internet voting platform to vote for the first time, investors need to complete shareholder identity authentication. For specific operations, please see
Internet voting platform website description.
(2) For a shareholder holding multiple shareholder accounts, the number of voting rights that can be exercised is the number of voting rights held by all shareholder accounts under his or her name.
The total number of common stocks of the same class and preferred stocks of the same variety.
Shareholders holding multiple shareholder accounts who participate in online voting at the general meeting of shareholders through the Exchange’s online voting system can participate through any of their shareholder accounts. After the voting, it shall be deemed that all ordinary shares of the same category and preferred shares of the same variety under all shareholder accounts have voted with the same opinion.
If a shareholder holding multiple shareholder accounts votes repeatedly through multiple shareholder accounts, the voting opinions of the same class of ordinary shares and the same type of preferred stocks under all shareholder accounts shall be based on the first voting results of each class and type of stocks respectively.
(3) If the same voting right is voted on repeatedly through on-site, online voting platform of the Exchange or other methods, the result of the first vote shall prevail.
(4) Shareholders must vote on all proposals before they can be submitted.
4. Participants at the meeting
(1) Shareholders of the company who are registered in the Shanghai Branch of China Securities Depository and Clearing Co., Ltd. after the market closes on the equity registration day have the right to attend the general meeting of shareholders (see the table below for details), and may entrust a proxy in writing to attend the meeting and participate in voting. The agent does not have to be a shareholder of the company.
Share class Stock code Stock abbreviation Equity registration date
A shares 603087 Ganli Pharmaceutical 2025/11/6
(2) Directors, supervisors and senior managers of the company.
(3) Lawyers hired by the company.
(4) Other personnel
5. Meeting registration method
(1) Registration time: Shareholders who meet the requirements for attending the meeting are required to go to the company's conference room to register on November 12, 2025 (Wednesday) (8:30-11:30 am, 13:30-17:30 pm) with relevant certificates.
(2) Registration location: Conference Room on the second floor of Ganli Pharmaceutical Co., Ltd., No. 8, Nanfengxi 1st Road, Miao County, Tongzhou District, Beijing.
(3) Registration method
If a natural person shareholder attends the meeting in person, he or she must present his or her original ID card and stock account card; if a natural person shareholder entrusts a proxy to attend the meeting, he or she must present the original stock account card and copy of his or her ID card, a power of attorney (see attachment 1 for the format of the power of attorney), and the original ID card of the trustee.
If a corporate shareholder is appointed by the legal representative/executive partner to attend the meeting in person, he or she should present the original ID card, the identity certificate of the legal representative/executive partner’s delegate, a copy of the corporate business license with official seal, and the original stock account card; If the legal representative/executive partner of a company's shareholders appoints a proxy to attend the meeting, the proxy should present his or her original ID card, a copy of the company's business license with official seal, the original stock account card, and a power of attorney (see attachment 1 for the format of the power of attorney).
The shareholders of the company can register by letter or email in accordance with the above requirements. The postmark of the letter and the arrival date of the email should be no later than 17:00 on November 12, 2025. The shareholder contact person, contact number and the words "Shareholders Meeting" must be indicated in the letter and email. Shareholders who register by letter or email are required to bring the above documents with them when attending the on-site meeting. The company does not accept registration by phone.
If shareholders or their authorized agents who intend to attend the meeting directly participate in the meeting without completing the registration formalities in advance as stipulated in this article, they should complete the registration formalities at the reception desk of the meeting site and provide the original or copy of the participation documents stipulated in this article to accept the qualification review.
6. Other matters
(1) This general meeting of shareholders will be held on-site for half a day. Shareholders or agents attending the meeting will be responsible for their own transportation, food and accommodation expenses.
(2) Shareholders or authorized representatives participating in the meeting are recommended to arrive at the meeting venue half an hour before the meeting and bring original ID cards, power of attorney, etc. for verification of admission.
(3) Contact information:
Contact person: Zou Rong
Contact number: 010-80593699
Email address: [email protected]
Contact address: Ganli Pharmaceutical Co., Ltd., No. 8, Nanfengxi 1st Road, Miao County, Tongzhou District, Beijing
Postal code: 101109
Announcement is hereby made.
Board of Directors of Ganli Pharmaceutical Co., Ltd.
October 31, 2025
Attachment 1: Power of attorney
Filing documents
Resolution of the fourth meeting of the fifth board of directors of Ganli Pharmaceutical Co., Ltd.
Attachment 1: Power of attorney
Power of attorney
Ganli Pharmaceutical Co., Ltd.:
I hereby authorize Mr. (Ms.) to represent the company (or myself) at your company’s first extraordinary general meeting of shareholders in 2025 to be held on November 17, 2025, and to exercise voting rights on your behalf.
Number of common shares held by the client:
Number of preferred shares held by the client:
Client shareholder account number:
Serial number Name of non-cumulative voting motion Agree Oppose Abstain 1 "About the abolition of the Board of Supervisors and the amendment of the Articles of Association"
and handle the proposal to change industrial and commercial registration”
2.00 "About the formulation and revision of some corporate governance systems"
motion"
2.01 "About the Revision of Ganli Pharmaceutical Co., Ltd.
Proposal of the Rules of Procedure of the Eastern Conference>
2.02 "About the Amendment<Director of Ganli Pharmaceutical Co., Ltd.
Proposal of "Rules of Procedure of the Council"
2.03 "About the Revision of Ganli Pharmaceutical Co., Ltd.'s
Proposal on External Guarantee System>
2.04 "About the Revision of Ganli Pharmaceutical Co., Ltd.'s
Proposal on Foreign Investment Management Measures>
2.05 "About the Revision of Ganli Pharmaceutical Co., Ltd.
"Proposal on Joint Transaction Management Measures"
2.06 "About the Revision of Ganli Pharmaceutical Co., Ltd. Independent
Proposal on the Establishment of the Director System>
2.07 "Proposal on Formulating the Remuneration Management Measures for Directors and Senior Management of Ganli Pharmaceutical Co., Ltd."
case"
2.08 "About the Formulation of Ganli Pharmaceutical Co., Ltd.'s Fund Raising
Proposal on Measures for the Management of Raised Funds>
2.09 "About the formulation of the meeting of Ganli Pharmaceutical Co., Ltd.
Proposal on Selection and Recruitment System for Accounting Firms>
Signature (stamped) of the principal: Signature of the trustee:
Trustee’s ID number: Trustee’s ID number:
Commission date: year month day
Remarks:
The client should choose one of the "agree", "objection" or "abstain" intentions in the power of attorney and tick "√". If the client does not give specific instructions in this power of attorney, the trustee has the right to vote according to his own wishes.